Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 10.90
-0.60 (-5.22%)
Last updated: Feb 6, 2026, 3:42 PM CET
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €86.53 million as of February 6, 2026. Its market cap has increased by 421.59% in one year.
Market Cap
86.53M
Enterprise Value
84.66M
Revenue
8.09M
Ranking
n/a
PE Ratio
44.32
Stock Price
€10.90
Market Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 86.53M, an increase of 463.02%. That is a compound annual growth rate of 55.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 86.53M | 34.50% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.69B |
| Laboratorios Farmaceuticos Rovi | 3.73B |
| Almirall | 2.76B |
| Faes Farma | 1.62B |
| Oryzon Genomics | 253.51M |
| Atrys Health | 225.35M |
| Laboratorio Reig Jofre | 224.64M |
| Prim, S.A. | 218.66M |